L-Tyrosyl-L-phenylalanine
-
L-Tyrosyl-L-phenylalanine
structure -
-
CAS No:
17355-11-2
-
Formula:
C18H20N2O4
-
Chemical Name:
L-Tyrosyl-L-phenylalanine
-
Synonyms:
L-Phenylalanine,L-tyrosyl-;Alanine,3-phenyl-N-L-tyrosyl-,L-;L-Phenylalanine,N-L-tyrosyl-;Alanine,3-phenyl-N-tyrosyl-;Alanine,3-phenyl-N-L-tyrosyl-;L-Tyrosyl-L-phenylalanine;33: PN: US20090239809 SEQID: 33 claimed protein;126: PN: WO2010017468 SEQID: 126 unclaimed protein;57: PN: EP2161028 PAGE: 10 claimed protein;4: PN: WO2018021471 PAGE: 16 claimed sequence
- Categories:
-
CAS No:
Characteristics
112.65000
2.16530
1.3 g/cm3
642.2ºC at 760 mmHg
342.2ºC
1.625
-20ºC
2.27E-17mmHg at 25°C
Computed Properties
Molecular Weight:328.4
XLogP3:-1.7
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:7
Exact Mass:328.14230712
Monoisotopic Mass:328.14230712
Topological Polar Surface Area:113
Heavy Atom Count:24
Complexity:415
Undefined Atom Stereocenter Count:2
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of L-Tyrosyl-L-phenylalanine
-
CN
5 YRS
Business licensedTrader Supplier of PVC resin,pvc paste resin,melamine
Latest News on L-Tyrosyl-L-phenylalanine
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
Dabrafenib
1195765-45-7
-
BOC-VAL-VAL-OH
69209-73-0
-
BMS 303141
943962-47-8
-
(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanamide Formula
60117-17-1
-
(2S)-2-acetamido-6-amino-N-[(2S)-2-amino-3-methylbutanoyl]-N-propylhexanamide Formula
57899-96-4
-
1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea Formula
26130-02-9
-
C-REACTIVE PROTEIN FRAGMENT 77-82 Structure
130349-01-8
-
Sildenafil Structure
139755-83-2
-
What is Dacomitinib
1110813-31-4
-
What is Lenvatinib
417716-92-8
Request for Quotation